Mo. Code Regs. Ann. tit. 13, § 70-2.200
PURPOSE: This rule establishes, via regulation, the Department of Social Services’/MO HealthNet Division’s guidelines regarding MO HealthNet coverage and reimbursement for human organ or bone marrow/stem cell transplants and related medical services. These policies will be administered by the MO HealthNet Division with the assistance and guidance of its medical consultant and/or transplant consultants.
(MHD) will provide limited coverage and reimbursement for the transplantation of human organs or bone marrow/stem cell and the related medical services, including, but not necessarily limited to, treatment and necessary pre-transplant and post-operative care for the specific procedures defined here and as further defined by the DSS/MHD and included in the provider program manuals.
(2) Conditions and Limitations.
(B) MO HealthNet benefits may be provided for transplantation of the following:
transplant).
(1) of which is covered under subsection (2)(B), may be covered at the recommendation of the medical consultant and/or transplant consultants.
(F) Approved organ transplants can only be performed in a facility which submits documentation approved by MHD as complying with the following criteria:
the national transplantation network and must provide a copy of a current effective certification from the United Network for Organ Sharing (UNOS) granting approval to perform a specific transplant(s). The certification from UNOS will be considered appropriate verification and documentation for MHD transplant facility approval;
transplant facility must provide MHD evidence that continued approval from UNOS allowing participation to perform the transplant(s) has been granted;
will be subject to separate UNOS certification for each type of organ transplant;
transplant surgeon who becomes a member of the transplant team. The transplant surgeons must be current MO HealthNet enrolled providers;
ment organization (OPO) presently utilized by the facility. The transplant facility must furnish a copy of the notification from Centers for Medicare and Medicaid Services (CMS) which designates the facility’s OPO as an acceptable organ procurement source;
report of the number of patients receiving transplants at the facility and the average charge for the inpatient transplant stay (by type of the transplant(s) performed) as defined by MHD in the provider program manual;
approved Kidney Transplant Center must furnish a copy of their current Medicare certification indicating active participation in the Medicare Renal Transplant Program; and
Transplantation Cases and Patient Selection Criteria for the type(s) of transplant(s) for which it is requesting transplant facility approval.
(G) Approved bone marrow/stem cell transplants can only be performed in a facility which submits documentation approved by MHD as complying with the following bone marrow/ stem cell transplant facility criteria. An autologous only transplant facility must meet criteria items one through ten (1–10) of the following:
bone marrow/stem cell transplantation, hematology, and oncology;
bone marrow/stem cell transplantation;
to supply required blood products or association with a qualified blood bank;
nology, pathology, and pulmonary medicine;
care and renal dialysis;
cell transplants a year or demonstrated an ability to care for prolonged marrow failure by treating twenty (20) adult or ten (10) pediatric marrow failure patients per year;
techniques or affiliation with a facility which has these capabilities;
and their families;
insure that all components of comprehensive care for patients undergoing bone marrow/stem cell transplantation are present in the facility. The mere presence or availability of the components one through eight (1–8) is not adequate. The facility must demonstrate that a coordinated bone marrow/stem cell transplantation program is in place and directed by a physician trained in an institution with a well established bone marrow/ stem cell transplantation program;
Transplantation Cases and Patient Selection Criteria for the type of bone marrow/stem cell transplants to be performed at the facility. Once approved as a facility each new type of bone marrow/stem cell transplant or diagnosis added for treatment by the facility must be documented by submitting the new protocol and patient selection criteria;
nology, pathology (of Graft vs. Host Disease), and pulmonary medicine;
typing for HLA-A, B, C, D/DR, and MLC;
ing Cyclosporine A.
(F) or (2)(G) and (2)(J) and (3)(A)—and they shall be financially at risk regarding state approval for any transplant related services rendered prior to the approval of its application.
(3) Procedure.
(A) The physician or transplant facility must make a written request to DSS/MHD for coverage of the transplant. This request must include, at a minimum, the following information:
sults;
volving out-of-state facilities, a statement from the patient’s physician explaining why the transplant procedure must be performed there. (Note: Those statements may be requested at the discretion of the MO HealthNet Division);
the patient’s diagnosis, as well as results of the facility’s completed transplant evaluation indicating that the patient meets the facility’s “Patient Selection Protocols;” and
history; availability of other medical or Medicare coverage (including ID number); correspondence from referring physician; consultation reports/letters; transplant evaluation forms; medical records and laboratory reports showing HIV status (within six (6) months of the request date); donor compatibility for bone marrow/stem cell transplants; and full psychiatric/social service evaluations with impression of participant’s ability to be an adequate transplant candidate (within six (6) months of request date).
(4) Reimbursement.
(A) Facility.
Division up to a maximum cap amount for the type of transplant authorized as listed in the Transplant Provider Manual at http://manuals.momed.com/manuals/. The cap will cover the costs associated with the transplant for the patient’s hospitalization from the date of the transplant procedure until the date of discharge. These charges will include organ procurement, donor costs or both, inpatient surgery costs, and all postsurgical hospital costs as defined in the provider program manual.
volving a transplant covered in subsection (2)(B), may not exceed the maximum of highest coverage for highest single transplant.
vices provided prior to the date of the transplant surgery or subsequent to the date of discharge will be made at established MO HealthNet Division reimbursable rates, excluding the period and reimbursement set out in and otherwise subject to the limitations as defined in the appropriate provider program manuals.
AUTHORITY: sections 208.153 and 208.201, RSMo Supp. 2013.* This rule was previously filed as 13 CSR 40-81.035. Emergency rule filed April 2, 1986, effective April 12, 1986, expired Oct. 10, 1986. Original rule filed April 2, 1986 effective June 28, 1986. Rescinded and readopted: Filed Jan. 17, 1990, effective April 26, 1990. Emergency amendment filed July 25, 1991, effective Aug. 5, 1991, expired Dec. 2, 1991. Emergency amendment filed Sept. 27, 1991, effective Oct. 7, 1991, expired Feb. 3, 1992, Amended: Filed Oct. 9, 1991, effective April 9, 1992. Emergency amendment filed Jan. 17, 1992, effective Feb. 4, 1992, expired June 2, 1992. Amended: Filed March 12, 2014, effective Sept. 30, 2014. *Original authority: 208.153, RSMo 1967, amended 1967, 1973, 1989, 1990, 1991, 2007, 2012 and 208.201, RSMo 1987, 2007.